Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rune Sandbu

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
The Journal of Clinical Endocrinology and Metabolism|August 31, 2021
Gastrointestinal Hormones and β-Cell Function After Gastric Bypass and Sleeve Gastrectomy: A Randomized Controlled Trial (Oseberg)Farhat Fatima, Jøran Hjelmesæth, Kåre Inge Birkeland, et al.
JAMA Surgery|September 15, 2016
Standard vs Distal Roux-en-Y Gastric Bypass in Patients With Body Mass Index 50 to 60: A Double-blind, Randomized Clinical TrialHilde Risstad, Marius Svanevik, Jon A Kristinsson, et al.
Obesity Surgery|March 21, 2020
Erosive Esophagitis and Symptoms of Gastroesophageal Reflux Disease in Patients with Morbid Obesity with and without Type 2 Diabetes: a Cross-sectional StudyJolanta Lorentzen, Asle W Medhus, Jens Kristoffer Hertel, et al.
BJS Open|November 18, 2021
Standard versus distal Roux-en-Y gastric bypass in patients with BMI 50-60 kg/m2: 5-year outcomes of a double-blind, randomized clinical trialOdd Bjørn Kjeldaas Salte, Marius Svanevik, Hilde Risstad, et al.
Annals of Internal Medicine|November 29, 2021
Gastric Bypass Versus Sleeve Gastrectomy in Type 2 Diabetes: Effects on Hepatic Steatosis and Fibrosis : A Randomized Controlled TrialKathrine Aglen Seeberg, Heidi Borgeraas, Dag Hofsø, et al.
Clinical and Translational Science|August 29, 2022
Impact of type 2 diabetes on in vivo activities and protein expressions of cytochrome P450 in patients with obesityKine Eide Kvitne, Anders Åsberg, Line K Johnson, et al.
Clinical Pharmacokinetics|November 22, 2023
Digoxin Pharmacokinetics in Patients with Obesity Before and After a Gastric Bypass or a Strict Diet Compared with Normal Weight IndividualsKine Eide Kvitne, Markus Hovd, Line Kristin Johnson, et al.
Plos One|March 20, 2015
Myotubes from severely obese type 2 diabetic subjects accumulate less lipids and show higher lipolytic rate than myotubes from severely obese non-diabetic subjectsSiril S Bakke, Yuan Z Feng, Natasa Nikolić, et al.
The Lancet. Diabetes & Endocrinology|November 4, 2019
Gastric bypass versus sleeve gastrectomy in patients with type 2 diabetes (Oseberg): a single-centre, triple-blind, randomised controlled trialDag Hofsø, Farhat Fatima, Heidi Borgeraas, et al.
Journal of Pharmaceutical Sciences|October 22, 2020
Correlation of Body Weight and Composition With Hepatic Activities of Cytochrome P450 EnzymesVeronica Krogstad, Alexandra Peric, Ida Robertsen, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
The Journal of Clinical Endocrinology and Metabolism|August 31, 2021
Gastrointestinal Hormones and β-Cell Function After Gastric Bypass and Sleeve Gastrectomy: A Randomized Controlled Trial (Oseberg)Farhat Fatima, Jøran Hjelmesæth, Kåre Inge Birkeland, et al.
JAMA Surgery|September 15, 2016
Standard vs Distal Roux-en-Y Gastric Bypass in Patients With Body Mass Index 50 to 60: A Double-blind, Randomized Clinical TrialHilde Risstad, Marius Svanevik, Jon A Kristinsson, et al.
Obesity Surgery|March 21, 2020
Erosive Esophagitis and Symptoms of Gastroesophageal Reflux Disease in Patients with Morbid Obesity with and without Type 2 Diabetes: a Cross-sectional StudyJolanta Lorentzen, Asle W Medhus, Jens Kristoffer Hertel, et al.
BJS Open|November 18, 2021
Standard versus distal Roux-en-Y gastric bypass in patients with BMI 50-60 kg/m2: 5-year outcomes of a double-blind, randomized clinical trialOdd Bjørn Kjeldaas Salte, Marius Svanevik, Hilde Risstad, et al.
Annals of Internal Medicine|November 29, 2021
Gastric Bypass Versus Sleeve Gastrectomy in Type 2 Diabetes: Effects on Hepatic Steatosis and Fibrosis : A Randomized Controlled TrialKathrine Aglen Seeberg, Heidi Borgeraas, Dag Hofsø, et al.
Clinical and Translational Science|August 29, 2022
Impact of type 2 diabetes on in vivo activities and protein expressions of cytochrome P450 in patients with obesityKine Eide Kvitne, Anders Åsberg, Line K Johnson, et al.
Clinical Pharmacokinetics|November 22, 2023
Digoxin Pharmacokinetics in Patients with Obesity Before and After a Gastric Bypass or a Strict Diet Compared with Normal Weight IndividualsKine Eide Kvitne, Markus Hovd, Line Kristin Johnson, et al.
Plos One|March 20, 2015
Myotubes from severely obese type 2 diabetic subjects accumulate less lipids and show higher lipolytic rate than myotubes from severely obese non-diabetic subjectsSiril S Bakke, Yuan Z Feng, Natasa Nikolić, et al.
The Lancet. Diabetes & Endocrinology|November 4, 2019
Gastric bypass versus sleeve gastrectomy in patients with type 2 diabetes (Oseberg): a single-centre, triple-blind, randomised controlled trialDag Hofsø, Farhat Fatima, Heidi Borgeraas, et al.
Journal of Pharmaceutical Sciences|October 22, 2020
Correlation of Body Weight and Composition With Hepatic Activities of Cytochrome P450 EnzymesVeronica Krogstad, Alexandra Peric, Ida Robertsen, et al.
Pageof 5